logo
#

Latest news with #KierenChidgey

UBS Remains a Hold on Suncorp Group (SNMYF)
UBS Remains a Hold on Suncorp Group (SNMYF)

Business Insider

time28-05-2025

  • Business
  • Business Insider

UBS Remains a Hold on Suncorp Group (SNMYF)

UBS analyst Kieren Chidgey maintained a Hold rating on Suncorp Group (SNMYF – Research Report) today and set a price target of A$21.65. The company's shares closed last Tuesday at $12.06. Confident Investing Starts Here: Chidgey covers the Financial sector, focusing on stocks such as ASX , Insurance Australia Group Limited, and Medibank Private. According to TipRanks, Chidgey has an average return of -0.5% and a 55.00% success rate on recommended stocks. Suncorp Group has an analyst consensus of Moderate Buy, with a price target consensus of $13.80. Based on Suncorp Group's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $7.35 billion and a net profit of $1.1 billion. In comparison, last year the company earned a revenue of $9.5 billion and had a net profit of $582 million Based on the recent corporate insider activity of 6 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SNMYF in relation to earlier this year.

UBS Reaffirms Their Buy Rating on QBE Insurance Group Limited (QBEIF)
UBS Reaffirms Their Buy Rating on QBE Insurance Group Limited (QBEIF)

Business Insider

time12-05-2025

  • Business
  • Business Insider

UBS Reaffirms Their Buy Rating on QBE Insurance Group Limited (QBEIF)

In a report released today, Kieren Chidgey from UBS maintained a Buy rating on QBE Insurance Group Limited (QBEIF – Research Report), with a price target of A$24.65. The company's shares closed last Wednesday at $13.50. Protect Your Portfolio Against Market Uncertainty Chidgey covers the Financial sector, focusing on stocks such as ASX , Medibank Private, and QBE Insurance Group Limited. According to TipRanks, Chidgey has an average return of -3.8% and a 43.75% success rate on recommended stocks. In addition to UBS, QBE Insurance Group Limited also received a Buy from Morgan Stanley's Andrei Stadnik in a report issued today. However, on the same day, Bell Potter maintained a Hold rating on QBE Insurance Group Limited (Other OTC: QBEIF). Based on QBE Insurance Group Limited's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $11.85 billion and a net profit of $977 million. In comparison, last year the company earned a revenue of $11.43 billion and had a net profit of $955 million Based on the recent corporate insider activity of 26 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of QBEIF in relation to earlier this year.

Medibank Private (MDBPF) Gets a Buy from UBS
Medibank Private (MDBPF) Gets a Buy from UBS

Business Insider

time07-05-2025

  • Business
  • Business Insider

Medibank Private (MDBPF) Gets a Buy from UBS

In a report released today, Kieren Chidgey from UBS maintained a Buy rating on Medibank Private (MDBPF – Research Report), with a price target of A$5.10. The company's shares closed last Thursday at $2.77. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Chidgey covers the Financial sector, focusing on stocks such as ASX , Medibank Private, and Insurance Australia Group Limited. According to TipRanks, Chidgey has an average return of -3.8% and a 43.75% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Medibank Private with a $2.99 average price target. MDBPF market cap is currently $8.36B and has a P/E ratio of 16.95.

UBS Keeps Their Sell Rating on ASX (ASXFF)
UBS Keeps Their Sell Rating on ASX (ASXFF)

Business Insider

time07-05-2025

  • Business
  • Business Insider

UBS Keeps Their Sell Rating on ASX (ASXFF)

In a report released today, Kieren Chidgey from UBS maintained a Sell rating on ASX (ASXFF – Research Report), with a price target of A$66.45. The company's shares closed last Thursday at $45.90. Protect Your Portfolio Against Market Uncertainty According to TipRanks, Chidgey is an analyst with an average return of -3.8% and a 43.75% success rate. Chidgey covers the Financial sector, focusing on stocks such as ASX , Medibank Private, and Insurance Australia Group Limited. In addition to UBS, ASX also received a Sell from Goldman Sachs's Julian Braganza in a report issued on May 1. However, on April 29, Macquarie maintained a Hold rating on ASX (Other OTC: ASXFF). The company has a one-year high of $48.10 and a one-year low of $36.25. Currently, ASX has an average volume of 906. Based on the recent corporate insider activity of 8 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ASXFF in relation to earlier this year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store